434 filings
Page 3 of 22
4
Mark S. Levine
29 Jan 24
Immunovant / Mark S. Levine ownership change
4:12pm
4
Michael Geffner
29 Jan 24
Immunovant / Michael Geffner ownership change
4:11pm
4
William L. Macias
19 Jan 24
Immunovant / William L. Macias ownership change
4:04pm
3
IMVT
Immunovant Inc
16 Jan 24
Immunovant / Michael Geffner ownership change
7:29am
4
IMVT
Immunovant Inc
12 Jan 24
Immunovant / Eva Renee Barnett ownership change
4:34pm
4
IMVT
Immunovant Inc
9 Jan 24
Immunovant / Julia G. Butchko ownership change
4:20pm
4
IMVT
Immunovant Inc
9 Jan 24
Immunovant / Peter Salzmann ownership change
4:18pm
8-K
IMVT
Immunovant Inc
9 Jan 24
Regulation FD Disclosure
8:08am
8-K
IMVT
Immunovant Inc
20 Dec 23
Immunovant Reports Positive Initial Phase 2 Results for Batoclimab in Graves’ Disease
4:37pm
4
IMVT
Immunovant Inc
5 Dec 23
Immunovant / Andrew J. Fromkin ownership change
4:30pm
4
IMVT
Immunovant Inc
5 Dec 23
Immunovant / Atul Pande ownership change
4:28pm
4
Migausky George V
5 Dec 23
Immunovant / GEORGE V MIGAUSKY ownership change
4:25pm
144
IMVT
Immunovant Inc
1 Dec 23
Notice of proposed sale of securities
4:20pm
144
IMVT
Immunovant Inc
1 Dec 23
Notice of proposed sale of securities
4:19pm
144
Migausky George V
1 Dec 23
Notice of proposed sale of securities
4:19pm
8-K
IMVT
Immunovant Inc
28 Nov 23
Immunovant Announces Positive IMVT-1402 Initial 600 mg MAD Results that Confirm Best-in-Class Potential
7:43am
4
IMVT
Immunovant Inc
24 Nov 23
Immunovant / Peter Salzmann ownership change
2:55pm
4
Eva Renee Barnett
24 Nov 23
Immunovant / Eva Renee Barnett ownership change
2:51pm
4
Butchko Julia G.
24 Nov 23
Immunovant / Julia G. Butchko ownership change
2:47pm
4
IMVT
Immunovant Inc
24 Nov 23
Immunovant / William L. Macias ownership change
2:45pm